Immunomedics is deeply committed to becoming the leading antibody drug conjugate (ADC) company worldwide, delivering breakthrough therapies to treat complex cancers and transform patient outcomes.
We will become a leading and integrated biopharmaceutical company dedicated to building, developing and commercializing a highly differentiated portfolio of targeted biologic therapies to transform patient outcomes based on clinical data and the deep scientific understanding of select solid tumor cancers and hematologic malignancies.
Our work is driven by scientific excellence and the highest standards, in a culture of integrity, pride and dedication. In doing so, we create value for our shareholders and a rewarding environment for our employees.
Given our commitment to excellence and innovation, we strive to find the most talented individuals who can support our corporate mission of improving health and the quality of life of patients with novel therapeutics for the treatment of cancer, autoimmune and other serious diseases.